The ethical hazards and programmatic challenges of genomic newborn screening

Affiliations

Aaron J Goldenberg et al. JAMA. 2012.

. 2012 Feb 1;307(5):461-2.

doi: 10.1001/jama.2012.68.

¹ Department of Bioethics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

No abstract available

Conflict of interest statement

Conflict of Interest: None of the authors have any conflicts of interest to report.

Genomic sequencing in newborn screening programs.
Greeley SA, Msall ME, Acharya K. Greeley SA, et al. JAMA. 2012 May 23;307(20):2146-7; author reply 2147. doi: 10.1001/jama.2012.3635. JAMA. 2012. PMID: 22618896 No abstract available.
Genomic sequencing in newborn screening programs.
Dondorp WJ, de Wert GM, Niermeijer MF. Dondorp WJ, et al. JAMA. 2012 May 23;307(20):2146; author reply 2147. doi: 10.1001/jama.2012.3621. JAMA. 2012. PMID: 22618913 No abstract available.

1. Ormond KE, Wheeler MT, Hudgins L, et al. Challenges in the clinical application of whole-genome sequencing. Lancet. 2010;375:1749–1751. - PubMed
1. Sharp RR. Downsizing genomic medicine: approaching the ethical complexity of whole-genome sequencing by starting small. Genet Med. 2011;13:191–194. - PubMed
1. Clayton EW. Currents in Contemporary Ethics. J Law med Ethics. 2010;38:697–700. - PubMed
1. Tarini BA, Christakis DA, Welch HG. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results. Pediatrics. 2006;118(2):448–456. - PubMed
1. Grosse SD, Boyle CA, Kenneson A, Khoury MJ, Wilfond BS. From public health emergency to public health service: the implications of evolving criteria fore newborn screening panels. Pediatrics. 2006;117(3):923–929. - PubMed